Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.
Advanced MRI screening may improve liver cancer detection in high-risk patients compared to standard ultrasound approaches.
Hepatocellular carcinoma (HCC) surveillance with semiannual ultrasound and AFP is guideline-recommended for patients with cirrhosis and selected patients with chronic hepatitis B. He is the co-Chair of the PREMIUM study, an ongoing randomized controlled trial comparing abbreviated MRI plus AFP versus ultrasound plus AFP for liver cancer screening sponsored by the US Department.
What the study was
- Study design
- Review/Perspective (ongoing RCT referenced)
- Population
- Patients with cirrhosis and selected patients with chronic hepatitis b
- Category
- Early Detection
- Maturity
- Potentially Practice-Changing
- Journal
- J Hepatol
Why it surfaced
Score 8/10 exceeds HIGH threshold (≥8) for this randomized controlled trial on Early cancer detection.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.